The global sterile injectable drugs market size was valued at USD 661.29 million in 2024 and is expected to reach USD 1,539.41 million by 2032, at a CAGR of 11.14% during the forecast period
The market growth is largely fueled by increasing demand for injectable drugs in hospitals, clinics, and outpatient care, along with advancements in sterile manufacturing technologies that ensure safety and efficacy
Furthermore, rising prevalence of chronic and acute diseases, coupled with growing adoption of biologics and specialty injectable therapies, is accelerating the uptake of sterile injectable drugs, thereby significantly boosting the industry's growth.
4 Ansichten